HK1131331A1 - Ocular allergy treatments - Google Patents

Ocular allergy treatments

Info

Publication number
HK1131331A1
HK1131331A1 HK09109552.2A HK09109552A HK1131331A1 HK 1131331 A1 HK1131331 A1 HK 1131331A1 HK 09109552 A HK09109552 A HK 09109552A HK 1131331 A1 HK1131331 A1 HK 1131331A1
Authority
HK
Hong Kong
Prior art keywords
ocular allergy
allergy treatments
treatments
ocular
allergy
Prior art date
Application number
HK09109552.2A
Other languages
English (en)
Inventor
Jagdish Parasrampuria
Avner Ingerman
Frans Janssens
Anton Megens
Original Assignee
Vistakon Pharmaceuticals Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38468943&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1131331(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Vistakon Pharmaceuticals Llc filed Critical Vistakon Pharmaceuticals Llc
Publication of HK1131331A1 publication Critical patent/HK1131331A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/04Antipruritics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/14Decongestants or antiallergics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
HK09109552.2A 2006-03-31 2009-10-15 Ocular allergy treatments HK1131331A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US78818506P 2006-03-31 2006-03-31
US68801607A 2007-03-19 2007-03-19
PCT/US2007/064911 WO2007117971A2 (en) 2006-03-31 2007-03-26 Ocular allergy treatments

Publications (1)

Publication Number Publication Date
HK1131331A1 true HK1131331A1 (en) 2010-01-22

Family

ID=38468943

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09109552.2A HK1131331A1 (en) 2006-03-31 2009-10-15 Ocular allergy treatments

Country Status (30)

Country Link
US (7) US8664215B2 (da)
EP (2) EP2004196B1 (da)
JP (3) JP5292277B2 (da)
KR (1) KR101321731B1 (da)
CN (1) CN102895234A (da)
AR (1) AR060278A1 (da)
AU (1) AU2007234957B2 (da)
BR (1) BRPI0710085B8 (da)
CA (1) CA2648115C (da)
CL (1) CL2007000916A1 (da)
CR (1) CR10414A (da)
DK (2) DK3150209T3 (da)
EA (1) EA016221B1 (da)
EC (1) ECSP088786A (da)
ES (2) ES2752823T3 (da)
HK (1) HK1131331A1 (da)
IL (1) IL194473A (da)
JO (1) JO3358B1 (da)
MX (1) MX2008012657A (da)
MY (1) MY153669A (da)
NI (1) NI200800261A (da)
NO (1) NO341147B1 (da)
NZ (1) NZ571690A (da)
PE (1) PE20080053A1 (da)
PL (2) PL2004196T3 (da)
SG (1) SG170044A1 (da)
TW (2) TWI578990B (da)
UY (1) UY30254A1 (da)
WO (1) WO2007117971A2 (da)
ZA (1) ZA200809327B (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3150209T3 (da) 2006-03-31 2019-10-28 Vistakon Pharmaceuticals Llc Okulære allergibehandlinger
AU2007243334A1 (en) 2006-04-26 2007-11-08 Aciex Therapeutics, Inc. Compositions for the treatment and prevention of eyelid swelling
JP2011503061A (ja) * 2007-11-08 2011-01-27 アーシエックス セラピューティックス, インコーポレイテッド 浸透圧活性剤及び血管収縮剤を含む眼けん腫脹の治療及び防止のための組成物
US8569273B2 (en) 2009-03-17 2013-10-29 Aciex Therapeutics, Inc. Ophthalmic formulations of cetirizine and methods of use
ES2910374T3 (es) 2009-03-17 2022-05-12 Nicox Ophthalmics Inc Formulaciones oftálmicas de cetirizina y procedimientos de uso
US10206813B2 (en) 2009-05-18 2019-02-19 Dose Medical Corporation Implants with controlled drug delivery features and methods of using same
EP2664329A1 (de) * 2012-05-15 2013-11-20 F. Holzer GmbH Ophthalmologisches Vehikelsystem
US9409913B2 (en) * 2012-11-21 2016-08-09 Enaltec Labs Private Limited Polymorphic forms of alcaftadine
WO2014087208A2 (en) * 2012-12-06 2014-06-12 Enaltec Labs Pvt. Ltd. A process of preparing alcaftadine
MX2019001633A (es) 2016-08-12 2019-09-18 Silk Tech Ltd Proteina derivada de la seda para el tratamiento de la inflamacion.
WO2019022225A1 (ja) * 2017-07-28 2019-01-31 参天製薬株式会社 アルカフタジン又はその塩を含有する水性医薬組成物
WO2019026992A1 (ja) * 2017-08-03 2019-02-07 参天製薬株式会社 クロルヘキシジンを含有する医薬組成物
CN111727035B (zh) * 2018-01-18 2024-05-28 费斯制药股份有限公司 包含比拉斯汀、β-环糊精和至少一种胶凝剂的眼用组合物
JP2023530166A (ja) 2020-06-15 2023-07-13 アルケム・ラボラトリーズ・リミテッド アルカフタジンとコルチコステロイドの組み合わせ
EP4312973A1 (en) 2021-04-01 2024-02-07 Alkem Laboratories Limited Nasal compositions comprising alcaftadine
WO2024010044A1 (ja) * 2022-07-06 2024-01-11 ロート製薬株式会社 眼科組成物
WO2024010039A1 (ja) * 2022-07-06 2024-01-11 ロート製薬株式会社 眼科組成物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4148903A (en) 1977-07-28 1979-04-10 Merck & Co., Inc. Antipsychotic, antiserotonin and antihistaminic pyrrolo[2,1-b][3]benzazepines
DE3134672A1 (de) 1981-09-02 1983-03-17 Boehringer Ingelheim KG, 6507 Ingelheim Heterocyclische verbindungen, ihre herstellung und verwendung
GB8900380D0 (en) 1989-01-09 1989-03-08 Janssen Pharmaceutica Nv 2-aminopyrimidinone derivatives
JPH089616B2 (ja) * 1990-10-10 1996-01-31 シェリング・コーポレーション 置換されたイミダゾベンズアゼピン類およびイミダゾピリドアゼピン類
IT1248014B (it) * 1991-06-07 1995-01-05 Inverni Della Beffa Spa Preparazioni oftalmiche a rilascio protratto
IL101850A (en) * 1991-06-13 1996-01-31 Janssen Pharmaceutica Nv History 11-) 4-Pipridinyl (-Imidazo] B-1, 2 [] 3 [Benzazepine, their preparation and pharmaceutical preparations containing them
US5641805A (en) 1995-06-06 1997-06-24 Alcon Laboratories, Inc. Topical ophthalmic formulations for treating allergic eye diseases
US20060100408A1 (en) * 2002-03-11 2006-05-11 Powell P M Method for forming contact lenses comprising therapeutic agents
US20070077302A1 (en) * 2005-09-30 2007-04-05 Azaam Alli Methods for stabilizing ophthalmic compositions
US20070077303A1 (en) 2005-09-30 2007-04-05 Azaam Alli Methods for providing oxidatively stable ophthalmic compositions
KR20150017002A (ko) 2006-03-17 2015-02-13 존슨 앤드 존슨 비젼 케어, 인코포레이티드 산화에 불안정한 성분을 포함하는 안정화된 눈용 조성물
DK3150209T3 (da) 2006-03-31 2019-10-28 Vistakon Pharmaceuticals Llc Okulære allergibehandlinger

Also Published As

Publication number Publication date
PL2004196T3 (pl) 2017-01-31
ES2594655T3 (es) 2016-12-21
JP2009533333A (ja) 2009-09-17
CA2648115C (en) 2015-03-24
US20120094978A1 (en) 2012-04-19
US20140107102A1 (en) 2014-04-17
US20210030762A1 (en) 2021-02-04
EA016221B1 (ru) 2012-03-30
JP6039716B2 (ja) 2016-12-07
US20240058355A1 (en) 2024-02-22
CR10414A (es) 2009-02-23
TWI578990B (zh) 2017-04-21
MX2008012657A (es) 2009-02-19
IL194473A (en) 2016-04-21
NO20084593L (no) 2008-10-29
NO341147B1 (no) 2017-09-04
SG170044A1 (en) 2011-04-29
IL194473A0 (en) 2009-08-03
NZ571690A (en) 2011-09-30
TW201446249A (zh) 2014-12-16
CL2007000916A1 (es) 2008-01-25
AR060278A1 (es) 2008-06-04
JP2013144703A (ja) 2013-07-25
WO2007117971A2 (en) 2007-10-18
KR20080110881A (ko) 2008-12-19
TWI450721B (zh) 2014-09-01
ES2752823T3 (es) 2020-04-06
JO3358B1 (ar) 2019-03-13
JP5292277B2 (ja) 2013-09-18
NI200800261A (es) 2012-10-30
EP3150209B1 (en) 2019-07-24
EP3150209A1 (en) 2017-04-05
EP2004196A2 (en) 2008-12-24
UY30254A1 (es) 2007-08-31
MY153669A (en) 2015-03-13
US8664215B2 (en) 2014-03-04
PE20080053A1 (es) 2008-03-10
US20080051385A1 (en) 2008-02-28
US20170065605A1 (en) 2017-03-09
BRPI0710085A2 (pt) 2011-08-23
CA2648115A1 (en) 2007-10-18
US20230181594A1 (en) 2023-06-15
AU2007234957B2 (en) 2012-12-13
ECSP088786A (es) 2009-01-30
CN102895234A (zh) 2013-01-30
BRPI0710085B1 (pt) 2019-12-17
TW200815016A (en) 2008-04-01
EA200870396A1 (ru) 2009-04-28
KR101321731B1 (ko) 2013-10-30
US10617695B2 (en) 2020-04-14
AU2007234957A1 (en) 2007-10-18
PL3150209T3 (pl) 2020-03-31
WO2007117971A3 (en) 2007-12-27
ZA200809327B (en) 2009-12-30
DK3150209T3 (da) 2019-10-28
DK2004196T3 (da) 2016-09-05
JP2015131820A (ja) 2015-07-23
EP2004196B1 (en) 2016-06-29
BRPI0710085B8 (pt) 2021-05-25

Similar Documents

Publication Publication Date Title
HK1131331A1 (en) Ocular allergy treatments
HK1219912A1 (zh) 眼放射外科
EP2020970A4 (en) TREATMENT OF THE EYE
GB0624874D0 (en) Treatment
EP1979023A4 (en) GLAUCOMA TREATMENT DEVICE
GB0602178D0 (en) Therapeutic treatment
EP1916974A4 (en) OPHTHALMIC INJECTOR
GB0600692D0 (en) Well treatment
GB0612242D0 (en) Retinal prosthetic devices
AU310899S (en) Eyewear
GB0608655D0 (en) Therapeutic Treatment
GB0702931D0 (en) Skin application
AU309458S (en) An eyeshield
GB0609919D0 (en) Goggles
GB0610909D0 (en) Therapeutic treatment
GB0607952D0 (en) Novel treatment
GB0604460D0 (en) Treatment
AU2014246580B9 (en) Ocular allergy treatments
GB0610376D0 (en) Therapeutic treatment
GB0622920D0 (en) Topical treatment
AU310898S (en) Eyewear
GB0602857D0 (en) The treatment of sialorrhoea
AU2006902304A0 (en) Eye treatment
GB0605781D0 (en) Treatment
GB0610431D0 (en) Treatment